Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lesch-Nyhan disease.

W L Nyhan1

  • 1Department of Pediatrics, University of California, San Diego, La Jolla, California 92093, USA. wnyhan@ucsd.edu

Nucleosides, Nucleotides & Nucleic Acids
|July 5, 2008
PubMed
Summary
This summary is machine-generated.

Lesch-Nyhan disease, a severe condition caused by hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency, presents with varied phenotypes. Numerous HPRT gene mutations contribute to the spectrum of this disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful Domino Liver Transplantation from a Patient with Methylmalonic Acidemia.

JIMD reports·2015
Same author

On being a Doctor... "and describe a disease not previously reported, Lesch--Nyhan disease".

Revista clinica espanola·2012
Same author

Positive newborn screen in the biochemically normal infant of a mother with treated holocarboxylase synthetase deficiency.

Journal of inherited metabolic disease·2009
Same author

The spectrum of mutations causing HPRT deficiency: an update.

Nucleosides, nucleotides & nucleic acids·2004
Same author

Emergency management of inherited metabolic diseases.

Journal of inherited metabolic disease·2003
Same author

Creatine kinase and uric acid: early warning for metabolic imbalance resulting from disorders of fatty acid oxidation.

European journal of pediatrics·2001
Same journal

Can the combination of 5-fluorouracil and gemcitabine increase the treatment efficacy of pancreatic and colon cancer?

Nucleosides, nucleotides & nucleic acids·2026
Same journal

"Aptamer-guided therapeutics and diagnostics for metabolic syndrome: Design, delivery, and translation of aptamer-based systems".

Nucleosides, nucleotides & nucleic acids·2026
Same journal

The impact of vitamin B12 deficiency on urinary profile of <i>de novo</i> purine synthesis intermediates: consequences of the methylfolate trap.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Evaluation of MTH1 and DCTPP1 inhibitors in fluorocyclopentenylcytosine (RX-3117) resistant lung cancer cells and potential cross resistance patterns.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Circular RNAs: promising biomarkers for diagnosis, prognosis and therapy in oral squamous cell carcinoma.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Gene therapy, RNA-based drugs, and CRISPR in neuroprotection.

Nucleosides, nucleotides & nucleic acids·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Neuroscience

Background:

  • Lesch-Nyhan disease is a rare genetic disorder characterized by a deficiency in the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT).
  • This deficiency leads to a spectrum of clinical presentations, ranging from severe neurological and behavioral abnormalities to milder forms with only hyperuricemia.
  • The enzyme HPRT plays a crucial role in purine metabolism.

Purpose of the Study:

  • To summarize the relationship between HPRT enzyme activity and the clinical phenotypes of Lesch-Nyhan disease.
  • To highlight the genetic basis of the disease, focusing on mutations within the HPRT gene.

Main Methods:

  • Review of existing literature and case studies on Lesch-Nyhan disease.
  • Analysis of genotype-phenotype correlations in patients with HPRT deficiency.

Related Experiment Videos

Main Results:

  • Complete HPRT deficiency results in the most severe phenotype, Lesch-Nyhan disease, with significant neurological and developmental impairments.
  • Partial HPRT deficiency is associated with intermediate phenotypes, including gout and neurological issues, with varying enzyme activity levels.
  • A wide array of mutations in the HPRT gene have been identified, explaining the diverse clinical manifestations.

Conclusions:

  • The severity of Lesch-Nyhan disease and its variants is directly correlated with the degree of HPRT enzyme deficiency.
  • Genetic mutations in the HPRT gene are the underlying cause of the spectrum of HPRT deficiency disorders.
  • Further research into HPRT mutations may lead to a better understanding and potential therapeutic strategies for these conditions.